Pharmalot By Ed Silverman The Omicron variant underscores the global stakes of Covid-19 vaccine inequity
Health By Andrew Joseph Scientists rapidly identified the Omicron variant. But firm answers about its impact could take weeks
Health By Andrew Joseph What’s known and unknown about Omicron, the coronavirus variant identified in South Africa
Biotech By Kate Sheridan Flagship Pioneering’s Noubar Afeyan on the crazy idea behind Moderna and professional entrepreneurs
Health By Helen Branswell FDA expands emergency authorization for Covid-19 booster shots to all adults
Pharmalot By Ed Silverman ‘Late is better than never’: Biden plan to boost U.S. production of Covid vaccines gets mixed reviews
Health By Helen Branswell Johnson and Johnson’s new vaccines leader talks Covid-19, pipeline plans, and ‘a golden opportunity’ for clinical trials
Health By Andrew Joseph Fauci on the next phase of the Covid-19 pandemic and the ‘insanity’ of the threats he faces for pushing masks, vaccines
First Opinion By Shaun Carstairs Why two emergency physicians’ kids took part in the Pfizer vaccine trials
Pharmalot By Ed Silverman ‘A work in progress’: BioNTech’s CEO wants to widen Covid-19 vaccine access on his own terms
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Moderna v. NIH, psilocybin as a medicine, & the cultural intake of pharma CEOs
First Opinion By Sanjula Jain and Jarrett Lewis Understanding health care consumer preferences is key to effective Covid-19 vaccination messaging
Health By Helen Branswell What would the public health experts do? STAT asked 28 about their holiday plans amid Covid-19
Health By Angus Chen The U.K. is on its way to eliminating cervical cancer. Here’s why the U.S. isn’t close
The Readout LOUD By Meg Tirrell and Adam Feuerstein Listen: Moderna’s setback, the saga of drug pricing reform & a CEO’s next act
Health By Isabella Cueto Mandates. A well-organized campaign. No politics. How Puerto Rico’s vaccine drive turned into a success
Politics By Maaisha Osman Can a pro-Covid vaccine, anti-mandate position help a Republican win in a Democratic state?
Pharmalot By Ed Silverman Pharmalittle: Pelosi tries last-ditch drug pricing proposal; Merck sees up to $7B in Covid pill sales in 2022
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Vaccines for kids, inside Operation Warp Speed, & a big biotech resignation
Health By Matthew Herper and Helen Branswell FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children
